Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence01:19

Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence

Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neurostimulation with Naming Therapy for Primary Progressive Aphasia: A Pilot Study Targeting Transcranial Direct Current (tDCS) Stimulation for the Individual.

Brain sciences·2026
Same author

Clinical recognition of frontotemporal dementia with right temporal predominance: a consensus statement from the International Working Group.

Communications medicine·2025
Same author

Associations between hysterectomy and pelvic floor disorders: a systematic review and meta-analysis.

American journal of obstetrics and gynecology·2025
Same author

Quantitative Imaging of Regional Cerebral Protein Synthesis in Clinical Alzheimer's Disease by [<sup>11</sup>C]Leucine PET.

Molecular imaging and biology·2024
Same author

Apraxia phenotypes and frontotemporal lobar degeneration.

Journal of neurology·2024
Same author

Clinical recognition of frontotemporal dementia with right anterior temporal predominance: A multicenter retrospective cohort study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2024

Related Experiment Video

Updated: May 24, 2026

Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
02:47

Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System

Published on: May 12, 2023

Challenge of surrogate endpoints.

James L Furgerson1, William N Hannah, Jennifer C Thompson

  • 1Department of Medicine, MCHE-MED Cardiology Service, Brooke Army Medical Center, Ft. Sam Houston, Texas 78234, USA. james.furgerson@amedd.army.mil

Southern Medical Journal
|March 7, 2012
PubMed
Summary

Surrogate endpoints, or biomarkers replacing clinical endpoints, aid drug discovery and trial efficiency. However, their broad application in clinical decisions requires extreme caution due to potential hazards.

Related Experiment Videos

Last Updated: May 24, 2026

Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
02:47

Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System

Published on: May 12, 2023

Area of Science:

  • Biomarkers and Clinical Trials
  • Translational Medicine
  • Drug Development

Background:

  • Biomarkers are increasingly used as surrogate endpoints in clinical research.
  • Surrogate endpoints offer potential benefits like accelerated drug approval and reduced trial costs.
  • The validity and application of surrogate endpoints require careful consideration.

Purpose of the Study:

  • To review the existing literature on surrogate endpoints.
  • To highlight the advantages and limitations of using surrogate endpoints.
  • To provide lessons learned from past studies employing surrogate endpoints.

Main Methods:

  • Literature review of studies utilizing surrogate endpoints.
  • Analysis of case studies and historical data.
  • Synthesis of expert opinions and published research.

Main Results:

  • Surrogate endpoints have successfully identified novel therapeutic targets.
  • They can enhance statistical power and reduce the duration of clinical trials.
  • Inappropriate use of surrogate endpoints can lead to erroneous conclusions and patient harm.

Conclusions:

  • While valuable tools, surrogate endpoints should be used judiciously.
  • Caution is advised when integrating surrogate endpoints into clinical decision-making.
  • Further research and validation are necessary to ensure the reliable use of surrogate endpoints.